Biopharma
AbbVie
AbbVie develops therapies in immunology, oncology, neuroscience, and eye care, building on the legacy of Humira with next-generation biologics. Its research collaborations with universities advance antibody-drug conjugates and targeted protein degradation.
$8.0B R&D Spend
Biopharma Industry
340 Academic Collaborations
22,000 Patents
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →